Executive Summary
The Insider Trading Pulse for 2026-10-21 covers 50 Form 4 filings, but the enriched period-over-period, forward-looking, capital allocation, and transaction valuation fields are largely absent from the supplied data; only summaries, key points, sentiment, and materiality are populated.
Activity is dominated by routine equity compensation (RSU/option awards, tax withholdings, and deferred-compensation credits at Erie Indemnity, Beneficient, Grupo Cibest, Heron Therapeutics) that carries little directional signal. The meaningful open-market activity is mostly sales, led by Pinterest director Silbermann (~$1.08M, 6 transactions), Hubspot director Halligan (~$2.04M), Gitlab director Sijbrandij (~$3.9M), Paylocity director Sarowitz (~$978K), and Castle Biosciences CEO Maetzold (~$274K), with several of these executed under Rule 10b5-1 plans. The few open-market purchases are small, including Veraxa director Ziegler (~$32.7K), Blend-adjacent and Sea-adjacent activity is limited, and 10% holder Saba Capital added stakes in Ellsworth and BNY Mellon Strategic Municipals. Given the missing enriched fields, conclusions rest on transaction-level data and should be treated as directional rather than quantified against prior periods.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior Insider Trading Pulse digest from October 20, 2026.
Investment Signals (11)
- Veraxa Biotech Holding AG ↓ (BULLISH)▲
Director Ziegler bought 30,000 shares at $1.09 (~$32.7K), raising holding to 37,932 shares, an open-market purchase rather than award
- OBOOK Holdings Inc. ↓ (BULLISH)▲
CEO Wang Chun Kai bought 12,192 Class A shares at $4.27 (~$52K), now holding 3.14M shares, a discretionary purchase by the top executive
- Saba Capital (10% owner) (BULLISH)▲
Bought 1,830 shares of Ellsworth Growth & Income Fund (~$20.8K, now 1.79M shares) and 7,724 shares of BNY Mellon Strategic Municipals (~$44.2K, now 6.44M shares), continued accumulation in closed-end funds
- Nebius Group N.V. ↓ (BULLISH)▲
Director Grimme bought ~$24.9K in two tranches at $164.62 and $167.94 (151 and 148 shares), although executed under a 10b5-1 plan, indicating a regular buying program
- PetVivo Holdings ↓ (BULLISH)▲
10% owner A.L. Sarroff Fund accumulated across 14 transactions at roughly $0.68-$0.74, with ~10.58M shares held, a sustained accumulation pattern
- Gitlab Inc. ↓ (BEARISH)▲
Director Sijbrandij sold 73,459 shares at $53.13 (~$3.9M) and a further 42,741 at $53.52 (~$2.29M), leaving 12.67M shares; large sale despite 10b5-1 structure
- Hubspot Inc. ↓ (BEARISH)▲
Director Halligan sold 8,500 shares at $239.57 (~$2.04M), retaining 59,500 shares, roughly 12.5% of the position reduced
- Pinterest, Inc. ↓ (BEARISH)▲
Director Silbermann sold 46,875 shares at $22.56 (~$1.06M) across six transactions after option/share exercises, with holdings reduced to 46,875; combined with director Rajaram's 1,050-share sale (~$24K) indicates post-exercise selling
- Castle Biosciences ↓ (BEARISH)▲
CEO Maetzold sold ~14,500 shares at $31.91 across three transactions (~$463K total), leaving only 4,114 shares directly held, a steep reduction in personal exposure under a 10b5-1 plan
- Paylocity Holding ↓ (BEARISH)▲
Director Sarowitz sold ~10,445 shares at $165.99-$166.47 (~$1.74M combined) under a 10b5-1 plan while retaining 4.41M shares, a small fraction of the holding
- Credo Technology ↓ (BEARISH)▲
CEO Brennan sold ~7,200 shares at $170-$173 across 11 transactions (~$1.2M combined) under a 10b5-1 plan, retaining 1.58M shares, consistent with scheduled diversification
Risk Flags (9)
- Gitlab Inc./Insider Selling↓ [HIGH RISK]▼
Director Sijbrandij disposed of ~116,000 shares (~$6.2M) in one session, the largest single-day insider sale in this set, though partly mitigated by a 10b5-1 plan and 12.67M shares retained
- Hubspot Inc./Insider Selling↓ [MEDIUM RISK]▼
Director Halligan's $2.04M sale is the largest open-market sale tied to a single transaction in a software name with materiality rated 6/10; signal strength depends on whether the plan was pre-scheduled
- Pinterest, Inc./Concentrated Director Selling↓ [MEDIUM RISK]▼
Two directors sold in the same session (Silbermann ~$1.06M, Rajaram ~$24K), with Silbermann's sale following option/share exercises, a pattern that can read as post-vesting liquidation rather than conviction
- Castle Biosciences/Executive Exposure Reduction↓ [HIGH RISK]▼
CEO Maetzold now holds only 4,114 directly reported shares after multiple 10b5-1 sales, a large relative reduction of personal stake that merits monitoring for further sales
- Paylocity Holding/Director Selling↓ [MEDIUM RISK]▼
Two sales by director Sarowitz within one filing (4,570 and 5,875 shares) totalling ~$1.74M, executed at nearly identical prices, suggesting a systematic liquidation schedule
- Sea Ltd/CFO Selling↓ [MEDIUM RISK]▼
CFO Hou Tianyu sold ~9,500 shares across three tranches (~$448K) with 35,000 shares remaining, following a 10b5-1 schedule; combined with CCO Wang Yanjun's sales (~$90K) at $90-$93, executives are steadily trimming near current levels
- Star Equity Holdings/CEO Preferred Sales↓ [LOW RISK]▼
CEO Eberwein sold 3,000 Series A preferred shares across three prints at $8.99-$9.11 (~$27K), indicating routine liquidity-driven disposals in a thinly traded security
- Imperial Petroleum/CEO Option Exercise↓ [LOW RISK]▼
CEO Vafias exercised 117,188 options at $3.20 (~$375K) without a disclosed sale, a mechanical exercise that warrants checking for subsequent dispositions
- Forbright, Inc./Share Disposition to Issuer↓ [LOW RISK]▼
Director Sachs disposed of 148,256 Class B shares to the issuer while being awarded an equal number of Class A shares, a conversion-like transaction that should be verified rather than read as a sale
Opportunities (7)
- Veraxa Biotech/Insider Buying Signal↓ (OPPORTUNITY)◆
Director Ziegler's 30,000-share open-market purchase at $1.09 is a rare discretionary buy in a sub-$2 equity, a potential early conviction signal worth tracking in subsequent filings
- OBOOK Holdings/CEO Accumulation↓ (OPPORTUNITY)◆
CEO Wang bought ~$52K at $4.27 while already holding 3.14M shares, signaling confidence at current levels; a follow-on buy would strengthen the case
- PetVivo Holdings/Sustained 10% Holder Buying↓ (OPPORTUNITY)◆
A.L. Sarroff Fund's 14 purchases at $0.68-$0.74 demonstrate persistent accumulation by a significant holder, supporting a constructive view despite low materiality rating of 2/10
- Nebius Group/Regular Director Purchase Plan↓ (OPPORTUNITY)◆
Director Grimme's 10b5-1 purchases at $164-$168 indicate an automated buying program, a low-noise positive signal that complements the company's other insider activity
- Saba Capital Closed-End Fund Accumulation (OPPORTUNITY)◆
Saba's continued buying in Ellsworth Growth & Income and BNY Mellon Strategic Municipals (combined ~$65K this session, holdings 1.79M and 6.44M shares) suggests a discount-capture strategy that may anticipate narrowing discounts
- Erie Indemnity/Director Deferred-Compensation Accrual↓ (OPPORTUNITY)◆
Four directors (Correnti, Datesh, Hagen J., Hagen T., Edwards) accrued Share Credits at $245.94, totalling ~$58K across filings; the uniform price and deferred structure reflect board alignment rather than sales pressure
- Beneficient/Board Equity Grants↓ (OPPORTUNITY)◆
Multiple directors (Cangany, Schnitzer, Hicks, Wendel) received 20,000-26,000 share awards, with Wendel and Cangany holdings growing materially, reinforcing board ownership alignment
Sector Themes (6)
- Software/Internet Insider Selling Under 10b5-1 Plans◆
Hubspot, Gitlab, Pinterest, Credo, and Paylocity directors and executives sold ~$6M+ in aggregate, nearly all under pre-arranged 10b5-1 plans, implying scheduled diversification rather than a sector-wide negative view [Implication: distinguish plan-driven from discretionary selling before reading sector sentiment]
- Closed-End Fund Accumulation by Activist-Style Holder◆
Saba Capital bought in at least two closed-end funds (Ellsworth, BNY Mellon Strategic Municipals) in the same session, consistent with a sector-wide discount-capture campaign across the CEF universe [Implication: monitor further 10% holder filings for expansion into other closed-end vehicles]
- Routine Equity Compensation Dominates Filings◆
Roughly 25 of 50 filings are award, tax-withholding, or deferred-comp transactions (Heron, Erie, Beneficient, Grupo Cibest, Xylem, American Public Education), which carry limited directional information and inflate filing counts [Implication: weight open-market transactions over headline filing counts]
- Director Deferred Compensation at Erie and Grupo Cibest◆
Uniform pricing across directors ($245.94 at Erie, $9.88 at Grupo Cibest) indicates board-wide plan participation, a governance-positive pattern [Implication: stable board alignment with no sign of selling pressure]
- Biotech/Life Sciences Routine Activity◆
Heron Therapeutics, Inhibikase, Castle Biosciences, and Pulsenmore show grants and option awards with a few 10b5-1 sales, a typical pre-catalyst compensation cycle [Implication: check for pending clinical or commercial milestones before interpreting sales]
- Asia-Based Issuers Show Executive Trimming◆
Sea Ltd and Valens Semiconductor insiders sold under 10b5-1 plans at current prices, while OBOOK's CEO bought, a divergence that could reflect differing liquidity needs rather than fundamentals [Implication: compare to Hong Kong and Israel-listed peer filings before drawing conclusions]
Watch List (8)
-
Director Sijbrandij's ~$6.2M in sales within one session warrants monitoring for additional tranches under the 10b5-1 plan; watch next Form 4 filings [date not provided in data]
-
CEO Maetzold retains only 4,114 direct shares after repeated sales; watch for further disposals or a change in executive compensation disclosure [date not provided in data]
-
Director Silbermann's exercise-and-sell pattern across six transactions suggests recurring liquidity events; monitor for continued exercises and dispositions [date not provided in data]
-
Director Ziegler's 30,000-share open-market purchase is the only discretionary buy from a board member in this set; watch for follow-on buying as confirmation of conviction [date not provided in data]
- Saba Capital (10% owner)👁
Continued accumulation in Ellsworth, BNY Mellon Strategic Municipals, and other CEFs; monitor for holding threshold changes or activist-style disclosures [date not provided in data]
-
Director Halligan's $2.04M sale is material relative to the 59,500 shares retained; watch for further 10b5-1 sales in the next filing window [date not provided in data]
- 👁
CFO Hou Tianyu holds 35,000 shares after three tranches; watch whether sales continue at ~$88-$90 levels [date not provided in data]
-
Director Sarowitz's two sales at ~$166 totalling ~$1.74M under a 10b5-1 plan; watch for a pattern of recurring tranches [date not provided in data]
Filing Analyses
(50)
21-10-2026
CFO Hou Tianyu sold 4,867 Class A ordinary shares at $88.54 (~$431K). 6 transactions reported in total. Hou Tianyu holds 35,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CFO Hou Tianyu sold 4,867 Class A ordinary shares at $88.54 (~$431K)
- · CFO Hou Tianyu sold 4,348 Class A ordinary shares at $89.16 (~$388K)
- · CFO Hou Tianyu sold 314 Class A ordinary shares at $90.22 (~$28.3K)
- · CFO Hou Tianyu sold 237 Class A ordinary shares at $91.60 (~$21.7K)
- · CFO Hou Tianyu sold 63 Class A ordinary shares at $91.98 (~$5.79K)
- · CFO Hou Tianyu sold 171 Class A ordinary shares at $93.00 (~$15.9K)
21-10-2026
CCO and GC Wang Yanjun sold 958 Class A ordinary shares at $90.29 (~$86.5K). 9 transactions reported in total. Wang Yanjun holds 75,980 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CCO and GC Wang Yanjun sold 958 Class A ordinary shares at $90.29 (~$86.5K)
- · CCO and GC Wang Yanjun sold 25 Class A ordinary shares at $91.77 (~$2.29K)
- · CCO and GC Wang Yanjun sold 17 Class A ordinary shares at $93.00 (~$1.58K)
- · CCO and GC Wang Yanjun sold 458 Class A ordinary shares at $80.76 (~$37K)
- · CCO and GC Wang Yanjun sold 165 Class A ordinary shares at $82.06 (~$13.5K)
- · CCO and GC Wang Yanjun sold 111 Class A ordinary shares at $82.99 (~$9.21K)
- · CCO and GC Wang Yanjun sold 60 Class A ordinary shares at $83.86 (~$5.03K)
- · CCO and GC Wang Yanjun sold 3 Class A ordinary shares at $85.40 (~$256)
21-10-2026
Chief Executive Officer WANG CHUN KAI bought 12,192 Class A Common Shares at $4.27 (~$52K). WANG CHUN KAI holds 3,137,000 shares after the transaction.
- · Chief Executive Officer WANG CHUN KAI bought 12,192 Class A Common Shares at $4.27 (~$52K)
21-10-2026
VP Finance Rozenberg Haine Yael sold 1,458 Ordinary Shares at $1.62 (~$2.36K). Rozenberg Haine Yael holds 135,859 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · VP Finance Rozenberg Haine Yael sold 1,458 Ordinary Shares at $1.62 (~$2.36K)
21-10-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
21-10-2026
Director Zapata Zuluaga Nicolas was awarded 457.66 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.52K).
- · Director Zapata Zuluaga Nicolas was awarded 457.66 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.52K)
21-10-2026
Director Restrepo Echavarria Luis Fernando was awarded 373.69 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$3.69K).
- · Director Restrepo Echavarria Luis Fernando was awarded 373.69 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$3.69K)
21-10-2026
Director Toro Valencia Juan Esteban was awarded 441.77 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.36K).
- · Director Toro Valencia Juan Esteban was awarded 441.77 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.36K)
21-10-2026
Director Jaramillo Mejia Ricardo was awarded 244.62 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$2.42K).
- · Director Jaramillo Mejia Ricardo was awarded 244.62 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$2.42K)
21-10-2026
Director Mejia Cardona Andres Felipe was awarded 640.58 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$6.33K).
- · Director Mejia Cardona Andres Felipe was awarded 640.58 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$6.33K)
21-10-2026
Director Correnti Salvatore acquired 18.21 Directors' Deferred Compensation Share Credits at $245.94 (~$4.48K).
- · Director Correnti Salvatore acquired 18.21 Directors' Deferred Compensation Share Credits at $245.94 (~$4.48K)
21-10-2026
EVP, Chief Financial Officer Duarte Ira had withheld for taxes 1,102 Common Stock at $0.36 (~$397). Duarte Ira holds 284,671 shares after the transaction.
- · EVP, Chief Financial Officer Duarte Ira exercised/converted 3,874 Common Stock
- · EVP, Chief Financial Officer Duarte Ira had withheld for taxes 1,102 Common Stock at $0.36 (~$397)
- · EVP, Chief Financial Officer Duarte Ira exercised/converted 3,874 Restricted Stock Units
21-10-2026
EVP, Chief Development Officer Forbes William P had withheld for taxes 1,102 Common Stock at $0.36 (~$397). Forbes William P holds 243,945 shares after the transaction.
- · EVP, Chief Development Officer Forbes William P exercised/converted 3,874 Common Stock
- · EVP, Chief Development Officer Forbes William P had withheld for taxes 1,102 Common Stock at $0.36 (~$397)
- · EVP, Chief Development Officer Forbes William P exercised/converted 3,874 Restricted Stock Units
21-10-2026
Director TISCH DANIEL R was awarded 2,023 Common Stock at $16.22 (~$32.8K). TISCH DANIEL R holds 91,784 shares after the transaction.
- · Director TISCH DANIEL R was awarded 2,023 Common Stock at $16.22 (~$32.8K)
21-10-2026
Director FISHBACK DONALD R gifted 4,200 Class A Common. FISHBACK DONALD R holds 4,200 shares after the transaction.
- · Director FISHBACK DONALD R gifted 4,200 Class A Common
- · Director FISHBACK DONALD R gifted 4,200 Class A Common
21-10-2026
Chief Executive Officer Collard Craig A had withheld for taxes 3,360 Common Stock at $0.36 (~$1.21K). Collard Craig A holds 866,929 shares after the transaction.
- · Chief Executive Officer Collard Craig A exercised/converted 13,797 Common Stock
- · Chief Executive Officer Collard Craig A had withheld for taxes 3,360 Common Stock at $0.36 (~$1.21K)
- · Chief Executive Officer Collard Craig A exercised/converted 13,797 Restricted Stock Units
21-10-2026
Director Datesh LuAnn acquired 26.469 Directors' Deferred Compensation Share Credits at $245.94 (~$6.51K).
- · Director Datesh LuAnn acquired 26.469 Directors' Deferred Compensation Share Credits at $245.94 (~$6.51K)
21-10-2026
Director Hagen Jonathan Hirt acquired 103.298 Directors' Deferred Compensation Share Credits at $245.94 (~$25.4K).
- · Director Hagen Jonathan Hirt acquired 103.298 Directors' Deferred Compensation Share Credits at $245.94 (~$25.4K)
21-10-2026
Director Edwards William David acquired 1.556 Directors' Deferred Compensation Share Credits at $245.94 (~$383).
- · Director Edwards William David acquired 1.556 Directors' Deferred Compensation Share Credits at $245.94 (~$383)
21-10-2026
Director Hagen Thomas B acquired 88.135 Directors' Deferred Compensation Share Credits at $245.94 (~$21.7K).
- · Director Hagen Thomas B acquired 88.135 Directors' Deferred Compensation Share Credits at $245.94 (~$21.7K)
21-10-2026
Chief Accounting Officer Laygo Sheryl had withheld for taxes 359 Common Stock at $22.16 (~$7.96K). Laygo Sheryl holds 13,793 shares after the transaction.
- · Chief Accounting Officer Laygo Sheryl had withheld for taxes 359 Common Stock at $22.16 (~$7.96K)
21-10-2026
10% owner Saba Capital Management, L.P. bought 1,830 Common Stock at $11.39 (~$20.8K). Saba Capital Management, L.P. holds 1,789,855 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 1,830 Common Stock at $11.39 (~$20.8K)
21-10-2026
EVP MOORE BRIAN DAVID disposed of 7 Common Stock at $4.37 (~$30.6). MOORE BRIAN DAVID holds 66,149 shares after the transaction.
- · EVP MOORE BRIAN DAVID disposed of 7 Common Stock at $4.37 (~$30.6)
21-10-2026
Director Sarowitz Steven I sold 5,875 Common Stock, par value $0.001 at $166.47 (~$978K). Sarowitz Steven I holds 4,414,756 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Sarowitz Steven I sold 4,570 Common Stock, par value $0.001 at $165.99 (~$759K)
- · Director Sarowitz Steven I sold 5,875 Common Stock, par value $0.001 at $166.47 (~$978K)
21-10-2026
HEAD OF BLEND Ghamsari Nima sold 27,775 Class A Common Stock at $0.92 (~$25.7K). Ghamsari Nima holds 7,750,693 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · HEAD OF BLEND Ghamsari Nima sold 27,775 Class A Common Stock at $0.92 (~$25.7K)
21-10-2026
Director CANGANY PETER T JR was awarded 25,689 Class A Common Stock. CANGANY PETER T JR holds 404,820 shares after the transaction.
- · Director CANGANY PETER T JR was awarded 25,689 Class A Common Stock
21-10-2026
Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 8,580 Common Stock at $31.91 (~$274K). MAETZOLD DEREK J holds 4,114 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 8,580 Common Stock at $31.91 (~$274K)
- · Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 3,198 Common Stock at $31.91 (~$102K)
- · Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 2,718 Common Stock at $31.91 (~$86.7K)
21-10-2026
Chief Commercial Officer Woods David was awarded 6,886 Options to Purchase Ordinary Shares.
- · Chief Commercial Officer Woods David was awarded 6,886 Options to Purchase Ordinary Shares
21-10-2026
Director Schnitzer Bruce William was awarded 23,300 Class A Common Stock. Schnitzer Bruce William holds 536,853 shares after the transaction.
- · Director Schnitzer Bruce William was awarded 23,300 Class A Common Stock
21-10-2026
Director Hicks Mack H. was awarded 20,910 Class A Common Stock. Hicks Mack H. holds 47,738 shares after the transaction.
- · Director Hicks Mack H. was awarded 20,910 Class A Common Stock
21-10-2026
Director Wendel Karen was awarded 25,689 Class A Common Stock. Wendel Karen holds 128,579 shares after the transaction.
- · Director Wendel Karen was awarded 25,689 Class A Common Stock
21-10-2026
EVP & Chief Financial Officer Codispoti Edward H had withheld for taxes 689 Common Stock, par value $.01 at $48.56 (~$33.5K). Codispoti Edward H holds 7,788 shares after the transaction.
- · EVP & Chief Financial Officer Codispoti Edward H had withheld for taxes 689 Common Stock, par value $.01 at $48.56 (~$33.5K)
21-10-2026
CFO Diaz Diana P had withheld for taxes 9 Class A Common Stock, par value $0.001 per share at $0.32 (~$2.88). Diaz Diana P holds 178 shares after the transaction.
- · CFO Diaz Diana P exercised/converted 28 Class A Common Stock, par value $0.001 per share
- · CFO Diaz Diana P had withheld for taxes 9 Class A Common Stock, par value $0.001 per share at $0.32 (~$2.88)
- · CFO Diaz Diana P exercised/converted 28 Restricted Stock Units
21-10-2026
CEO and President Vafias Harry exercised/converted 117,188 Common Stock at $3.20 (~$375K). Vafias Harry holds 3,918,196 shares after the transaction.
- · CEO and President Vafias Harry exercised/converted 117,188 Common Stock at $3.20 (~$375K)
- · CEO and President Vafias Harry exercised/converted 117,188 Stock Option (Right to Buy)
21-10-2026
Director Halligan Brian sold 8,500 Common Stock at $239.57 (~$2.04M). Halligan Brian holds 59,500 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Halligan Brian sold 8,500 Common Stock at $239.57 (~$2.04M)
21-10-2026
Pres & Chief Executive Officer Brennan William Joseph sold 3,186 Ordinary Shares at $173.37 (~$552K). 11 transactions reported in total. Brennan William Joseph holds 1,584,164 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Pres & Chief Executive Officer Brennan William Joseph sold 769 Ordinary Shares at $170.39 (~$131K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 568 Ordinary Shares at $171.50 (~$97.4K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 2,694 Ordinary Shares at $172.54 (~$465K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 3,186 Ordinary Shares at $173.37 (~$552K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 2,592 Ordinary Shares at $174.50 (~$452K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 1,624 Ordinary Shares at $175.36 (~$285K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 1,490 Ordinary Shares at $176.36 (~$263K)
- · Pres & Chief Executive Officer Brennan William Joseph sold 1,232 Ordinary Shares at $177.44 (~$219K)
21-10-2026
Director Sachs Lewis A disposed to the issuer 148,256 Class B Common Stock. Sachs Lewis A holds 3,326,507 shares after the transaction.
- · Director Sachs Lewis A disposed to the issuer 148,256 Class B Common Stock
- · Director Sachs Lewis A was awarded 148,256 Class A Common Stock
21-10-2026
10% owner Saba Capital Management, L.P. bought 7,724 Common Stock at $5.72 (~$44.2K). Saba Capital Management, L.P. holds 6,436,358 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 7,724 Common Stock at $5.72 (~$44.2K)
21-10-2026
Director Ziegler Christoph Samuel bought 30,000 Ordinary Shares at $1.09 (~$32.7K). Ziegler Christoph Samuel holds 37,932 shares after the transaction.
- · Director Ziegler Christoph Samuel bought 30,000 Ordinary Shares at $1.09 (~$32.7K)
21-10-2026
Director ANDERSON DAVID HUGO sold 1,500 Common Stock at $48.71 (~$73.1K). ANDERSON DAVID HUGO holds 47,759 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director ANDERSON DAVID HUGO sold 1,500 Common Stock at $48.71 (~$73.1K)
21-10-2026
Director Grimme Arne bought 151 Class A Shares at $164.62 (~$24.9K). Grimme Arne holds 6,628 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Grimme Arne bought 151 Class A Shares at $164.62 (~$24.9K)
- · Director Grimme Arne bought 148 Class A Shares at $167.94 (~$24.9K)
21-10-2026
Director Wasserman Scott M. was awarded 310,000 Stock Option (Right to Buy).
- · Director Wasserman Scott M. was awarded 310,000 Stock Option (Right to Buy)
21-10-2026
Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $9.11 (~$9.11K). Eberwein Jeffrey E. holds 750,936 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $9.11 (~$9.11K)
- · Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $9.10 (~$9.1K)
- · Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $8.99 (~$8.99K)
21-10-2026
CFO and Treasurer Mandel Matthew Charles was awarded 175,083 Class A Common Stock. Mandel Matthew Charles holds 175,083 shares after the transaction.
- · CFO and Treasurer Mandel Matthew Charles was awarded 175,083 Class A Common Stock
21-10-2026
Director Silbermann Benjamin sold 46,875 Class A Common Stock at $22.94 (~$1.08M). 6 transactions reported in total. Silbermann Benjamin holds 46,875 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Silbermann Benjamin exercised/converted 46,875 Class A Common Stock
- · Director Silbermann Benjamin sold 46,875 Class A Common Stock at $22.56 (~$1.06M)
- · Director Silbermann Benjamin exercised/converted 46,875 Class A Common Stock
- · Director Silbermann Benjamin sold 46,875 Class A Common Stock at $22.94 (~$1.08M)
- · Director Silbermann Benjamin exercised/converted 46,875 Class B Common Stock
- · Director Silbermann Benjamin exercised/converted 46,875 Class B Common Stock
21-10-2026
Director Morris Scott James was awarded 3,806 Common Stock. Morris Scott James holds 3,807 shares after the transaction.
- · Director Morris Scott James was awarded 3,806 Common Stock
21-10-2026
Director Rajaram Gokul sold 1,050 Class A Common Stock at $22.84 (~$24K). Rajaram Gokul holds 35,146 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Rajaram Gokul sold 1,050 Class A Common Stock at $22.84 (~$24K)
21-10-2026
Director Sijbrandij Sytse sold 73,459 Class A Common Stock at $53.13 (~$3.9M). Sijbrandij Sytse holds 12,669,651 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Sijbrandij Sytse sold 73,459 Class A Common Stock at $53.13 (~$3.9M)
- · Director Sijbrandij Sytse sold 42,741 Class A Common Stock at $53.52 (~$2.29M)
21-10-2026
10% owner A.L. Sarroff Fund, LLC bought 10,000 Common Stock at $0.74 (~$7.4K). 14 transactions reported in total. A.L. Sarroff Fund, LLC holds 10,577,186 shares after the transaction.
- · 10% owner A.L. Sarroff Fund, LLC bought 9,000 Common Stock at $0.68 (~$6.12K)
- · 10% owner A.L. Sarroff Fund, LLC bought 4,000 Common Stock at $0.70 (~$2.8K)
- · 10% owner A.L. Sarroff Fund, LLC bought 4,000 Common Stock at $0.70 (~$2.8K)
- · 10% owner A.L. Sarroff Fund, LLC bought 4,000 Common Stock at $0.70 (~$2.8K)
- · 10% owner A.L. Sarroff Fund, LLC bought 4,286 Common Stock at $0.72 (~$3.09K)
- · 10% owner A.L. Sarroff Fund, LLC bought 10,000 Common Stock at $0.74 (~$7.4K)
- · 10% owner A.L. Sarroff Fund, LLC bought 10,000 Common Stock at $0.74 (~$7.4K)
- · 10% owner A.L. Sarroff Fund, LLC bought 3,000 Common Stock at $0.70 (~$2.1K)
21-10-2026
EVP & President, MCS Emmerich Meredith had withheld for taxes 837 Common Stock at $106.35 (~$89K). Emmerich Meredith holds 4,610 shares after the transaction.
- · EVP & President, MCS Emmerich Meredith had withheld for taxes 837 Common Stock at $106.35 (~$89K)
Get daily alerts with 11 investment signals, 9 risk alerts, 7 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Insider Trading Pulse
🇺🇸 More from United States
View all →October 21, 2026
US Pre-Market SEC Filings Roundup — October 21, 2026
US Pre-Market SEC Filings Roundup
October 21, 2026
US Corporate Board Director Changes SEC Filings — October 21, 2026
US Corporate Board Director Changes SEC Filings
October 21, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — October 21, 2026
S&P 500 Consumer Discretionary Sector SEC Filings
October 21, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — October 21, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings